SCHEMBL8868013

SCHEMBL8868013

CCNC(=O)c1ccc(S(=O)(=O)NC(=O)c2ccc(C(=O)NCCOCC)nc2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P4HTM Q9NXG6 5/20 0.50
EGFR P00533 2/20 0.46
CA2 P00918 2/20 0.42
FLT1 P17948 1/20 0.41
FLT4 P35916 1/20 0.41
KDR P35968 1/20 0.41
HPGD P15428 3/20 0.41
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
KDM4E B2RXH2 1/20 0.40
ALDH1A1 P00352 1/20 0.40
MAPT P10636 1/20 0.40
CCNC P24863 1/20 0.40
CDK8 P49336 1/20 0.40
CDK19 Q9BWU1 1/20 0.40
EGLN1 Q9GZT9 1/20 0.40
LMNA P02545 1/20 0.39
MAPK1 P28482 1/20 0.39
KMT2A Q03164 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8869631 0.97 P4HTM (0.53) P4HTMEGFRCA2FLT1FLT4
SCHEMBL8869667 0.94 P4HTM (0.53) P4HTMEGFRCA2FLT1FLT4
SCHEMBL8868196 0.94 P4HTM (0.53) P4HTMEGFRCA2FLT1FLT4
SCHEMBL8867931 0.93 HPGD (0.51) P4HTMEGFRHPGDNPC1RAB9A
SCHEMBL8869333 0.92 P4HTM (0.48) P4HTMEGFRCA2FLT1FLT4
SCHEMBL8869755 0.92 P4HTM (0.54) P4HTMEGFRFLT1FLT4KDR
SCHEMBL8868438 0.91 P4HTM (0.48) P4HTMEGFRCA2FLT1FLT4
SCHEMBL9138259 0.91 P4HTM (0.61) P4HTMEGFRCA2HPGDNPC1
SCHEMBL8869712 0.90 CA2 (0.50) P4HTMEGFRCA2HPGDNPC1
SCHEMBL8869447 0.90 P4HTM (0.49) P4HTMEGFRCA2FLT1FLT4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5607954-A Sulfonamido- and sulfonamidocarbonylpyridine-2-carboxamides and their pyridine-n-oxides, process for their preparation and their use as pharmaceuticals HOECHST AKTIENGESELLSCHAFT (DE) 1997-03-04 US disclosed